ABERNATHY JAMES PAUL 4
4 · NATIONAL HEALTHCARE CORP · Filed Jan 8, 2024
Insider Transaction Report
Form 4
ABERNATHY JAMES PAUL
Director
Transactions
- Exercise/Conversion
Shares of Common Stock
2024-01-04$64.64/sh+7,500$484,800→ 38,323 total - Exercise/Conversion
Shares of Common Stock
2024-01-04$77.92/sh+5,895$459,338→ 35,735 total - Exercise/Conversion
Option to Purchase Common Stock
2024-01-04−5,895→ 0 totalExercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (5,895 underlying) - Tax Payment
Shares of Commmon Stock
2024-01-04$93.50/sh−4,912$459,272→ 30,823 total - Exercise/Conversion
Option to Purchase Common Stock [2020 Grant]
2024-01-04−7,500→ 0 totalExercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - Tax Payment
Shares of Common Stock
2024-01-04$93.50/sh−5,185$484,798→ 33,138 total
Holdings
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2021 Grant]
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying)
Footnotes (4)
- [F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]Shares were withheld by the Company to pay the exercise price.
- [F3]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F4]Total amount of shares beneficially owned following transactions reported on this form.